Biomarkers in Saliva in Children With Juvenil Idiopathic Arthritis
NCT02223195 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2020-08-05
Summary
Purpose and aims This as a pilot study that aims to investigate which inflammatory biomarkers can be found in saliva in children with Juvenile Idiopathic Arthritis (JIA).
The hypothesis is that children with JIA will show a different pattern of inflammatory biomarkers in saliva than healthy Children.
The null hypothesis is that there are no differences.
Conditions
- Juvenile Idiopathic Arthritis
Sponsors & Collaborators
-
Folktandvården Stockholms län AB
lead OTHER_GOV
Principal Investigators
-
Britt Hedenberg Magnusson, PhD DDS · Karolinska Institutet
Eligibility
- Min Age
- 7 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2019-10-31
- Completion
- 2019-10-31
Countries
- Sweden
Study Locations
More Related Trials
-
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
NCT05609630 ·Status: RECRUITING ·Phase: PHASE3
-
Biomarkers in Idiopathic Juvenile Arthritis
NCT02343770 ·Status: UNKNOWN ·Phase: NA
-
23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy
NCT02196480 ·Status: COMPLETED ·Phase: PHASE4
-
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
NCT00889863 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Disease Subtypes and Therapy
NCT06413563 ·Status: NOT_YET_RECRUITING
-
Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis
NCT06007456 ·Status: RECRUITING
-
Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
NCT00426218 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
NCT00144599 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
NCT06668181 ·Status: RECRUITING ·Phase: PHASE3
-
An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
NCT02776735 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients
NCT02492217 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)
NCT05411211 ·Status: COMPLETED
-
BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
NCT00095173 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience
NCT05182203 ·Status: COMPLETED
-
Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
NCT00144625 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
NCT04527380 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases
NCT04397107 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis
NCT00731965 ·Status: COMPLETED ·Phase: PHASE4
-
Pediatric Arthritis Study of Certolizumab Pegol
NCT01550003 ·Status: COMPLETED ·Phase: PHASE3
-
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
NCT02991469 ·Status: RECRUITING ·Phase: PHASE2
-
Start Time Optimization of Biologics in Polyarticular JIA
NCT02593006 ·Status: COMPLETED
-
Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response
NCT02240888 ·Status: COMPLETED ·Phase: NA
-
Tofacitinib in Juvenile Idiopathic Arthritis
NCT07211932 ·Status: NOT_YET_RECRUITING
-
A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis
NCT00988221 ·Status: COMPLETED ·Phase: PHASE3
-
Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
NCT01015547 ·Status: COMPLETED ·Phase: PHASE3